179 related articles for article (PubMed ID: 19222856)
1. Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity.
Freeburg EM; Goyeneche AA; Seidel EE; Telleria CM
Cancer Cell Int; 2009 Feb; 9():4. PubMed ID: 19222856
[TBL] [Abstract][Full Text] [Related]
2. Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity.
Gamarra-Luques CD; Hapon MB; Goyeneche AA; Telleria CM
J Ovarian Res; 2014; 7():45. PubMed ID: 24795781
[TBL] [Abstract][Full Text] [Related]
3. Mifepristone abrogates repopulation of ovarian cancer cells in between courses of cisplatin treatment.
Freeburg EM; Goyeneche AA; Telleria CM
Int J Oncol; 2009 Mar; 34(3):743-55. PubMed ID: 19212679
[TBL] [Abstract][Full Text] [Related]
4. Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy.
Gamarra-Luques CD; Goyeneche AA; Hapon MB; Telleria CM
BMC Cancer; 2012 Jun; 12():200. PubMed ID: 22642877
[TBL] [Abstract][Full Text] [Related]
5. [Effects of mifepristone on the proliferation, apoptosis, and cis-platinum (DDP) sensitivity of chemo-resistant human ovarian cancer cells].
Wang G; Zheng WT; Xiao P; Li XJ; Lin TC; Li GY
Ai Zheng; 2004 Apr; 23(4):406-11. PubMed ID: 15087028
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
Henkels KM; Turchi JJ
Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
[TBL] [Abstract][Full Text] [Related]
7. Sustained suppression of Fas ligand expression in cisplatin-resistant human ovarian surface epithelial cancer cells.
Schneiderman D; Kim JM; Senterman M; Tsang BK
Apoptosis; 1999 Aug; 4(4):271-81. PubMed ID: 14692397
[TBL] [Abstract][Full Text] [Related]
8. Mifepristone inhibits ovarian cancer cell growth in vitro and in vivo.
Goyeneche AA; Carón RW; Telleria CM
Clin Cancer Res; 2007 Jun; 13(11):3370-9. PubMed ID: 17545545
[TBL] [Abstract][Full Text] [Related]
9. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
Ma JJ; Chen BL; Xin XY
Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis in cisplatin-sensitive and -resistant human ovarian cancer cell lines.
Henkels KM; Turchi JJ
Cancer Res; 1997 Oct; 57(20):4488-92. PubMed ID: 9377558
[TBL] [Abstract][Full Text] [Related]
12. Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo: involvement of p38 MAPK activation.
Zhang B; Wang X; Cai F; Chen W; Loesch U; Zhong XY
Oncol Rep; 2013 Apr; 29(4):1371-8. PubMed ID: 23338561
[TBL] [Abstract][Full Text] [Related]
13. Triptolide antagonized the cisplatin resistance in human ovarian cancer cell line A2780/CP70 via hsa-mir-6751.
Wang R; Ma X; Su S; Liu Y
Future Med Chem; 2018 Aug; 10(16):1947-1955. PubMed ID: 29966441
[TBL] [Abstract][Full Text] [Related]
14. Association between circadian gene
Xu H; Wang Z; Mo G; Chen H
Oncol Lett; 2018 Jun; 15(6):8945-8950. PubMed ID: 29844814
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
16. Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells.
Gaddy VT; Barrett JT; Delk JN; Kallab AM; Porter AG; Schoenlein PV
Clin Cancer Res; 2004 Aug; 10(15):5215-25. PubMed ID: 15297425
[TBL] [Abstract][Full Text] [Related]
17. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
Yang XK; Xing H; Zheng F; Gao QL; Wang W; Lu YP; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691
[TBL] [Abstract][Full Text] [Related]
18. Effect of tumor suppressor gene PTEN on the resistance to cisplatin in human ovarian cancer cell lines and related mechanisms.
Wu H; Cao Y; Weng D; Xing H; Song X; Zhou J; Xu G; Lu Y; Wang S; Ma D
Cancer Lett; 2008 Nov; 271(2):260-71. PubMed ID: 18657898
[TBL] [Abstract][Full Text] [Related]
19. Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines.
Brown R; Clugston C; Burns P; Edlin A; Vasey P; Vojtĕsek B; Kaye SB
Int J Cancer; 1993 Oct; 55(4):678-84. PubMed ID: 8406999
[TBL] [Abstract][Full Text] [Related]
20. High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.
Kozubík A; Horváth V; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Zák F; Mistr A; Turánek J
Biochem Pharmacol; 2005 Feb; 69(3):373-83. PubMed ID: 15652229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
